Collaboration License. Subject to the terms and conditions of this Agreement, Tekmira hereby grants Alnylam a non-exclusive, royalty-free license under (i) Tekmira Technology and Tekmira Collaboration IP, and (ii) Tekmira IOC Technology that is Controlled by Tekmira on the Original Effective Date and during the Collaboration Term, as permitted and solely for the purposes of performing Alnylam’s obligations under the Collaboration with respect to Tekmira Royalty Products in accordance with the Research Plan as set forth in Article 3. Such license does not include the right to grant sublicenses except to subcontractors of Alnylam permitted under Section 3.5.
Collaboration License. C4 hereby grants to Biogen and its Affiliates, during the Collaboration Term, a royalty-free, worldwide, exclusive (even as to C4, except to the extent necessary for C4 to perform any Collaboration Activities under any Candidate Development Plan or expressly allocated to C4 under the Sandbox Plan) license, with the right to sublicense through multiple tiers (subject to the provisions of Section 2.1.4 (Sublicensing by Biogen)), under the C4 Licensed Technology solely for the purpose of performing (or having performed) Candidate Development Activities (except to the extent required for C4 to perform the Candidate Development Activities assigned to C4 under the Candidate Development Plans) under each Candidate Development Plan and Sandbox Activities under the Sandbox Plan.
Collaboration License. Biogen hereby grants to C4, during the Collaboration Term, a royalty-free, non-exclusive, worldwide license, with the right to sublicense through multiple tiers (subject to the provisions of Section 2.2.3 (Sublicensing by C4)), under the Biogen Licensed Technology solely for the purpose of performing the C4 Candidate Development Activities under the applicable Candidate Development Plan, and to the extent allocated to C4 under the Sandbox Plan, the Sandbox Activities.
Collaboration License. Subject to the terms and conditions of this Agreement, Mylan hereby grants to Momenta, effective as of the Effective Date, a co-exclusive (with Mylan), non-transferable, right and license, in the Field in the Territory, with the right to grant sublicenses solely as agreed to by the Parties [***], under the Mylan Intellectual Property solely to: (i) perform its activities under the applicable Product Work Plan(s) to Develop and Manufacture the Products; and (ii) to the extent Momenta has rights to Commercialize the Products pursuant to Section 2.7 to perform its activities under the applicable Commercialization Plan and Co-Commercialization Agreement.
Collaboration License. Subject to the terms and conditions of this Agreement, TSVT and its Affiliates hereby grant to JW and its Affiliates, a non-exclusive, non- transferable (except as permitted under Section 14.5), sublicensable (subject to Section 8.2), right to and license under the TSVT IP for JW and its Affiliates to perform JW’s activities assigned under and in accordance with the Territory Specific Development Plan.
Collaboration License. Hyseq hereby grants to ACY a worldwide, exclusive right and license under Hyseq Technology, Hyseq Patents and Hyseq's interests in Joint Patents to discover, develop, make, have made, use, import, offer for sale, and to sell ACY Products in the * , subject to the payment of royalties as applicable and in accordance with Article 5 herein. Said license shall extend until termination of the Collaboration, and then shall apply only to each Designated Organism Family for one (1) year post termination of the Collaboration.
Collaboration License. Subject to the terms and conditions of this Agreement, Metabasis hereby grants to Merck, during the Research Term, an exclusive (even as to Metabasis, except as set forth below in this Section 4.1(a)(i)), worldwide, royalty free license, without the right to sublicense except as permitted under Section 2.3, under the Metabasis Technology and Metabasis’ interest in the Joint Technology solely to perform Merck’s obligations under the Research Plan as expressly authorized by this Agreement. The exclusivity of the foregoing license shall be subject to Metabasis’ retained right to practice under the Metabasis Technology and the Joint Technology solely to perform Metabasis’ obligations under the Research Plan as expressly authorized by this Agreement and to practice under the Metabasis Technology and the Joint Technology for purposes other than research, development and commercialization of Collaboration Compounds and Products.
Collaboration License. Subject to the terms and conditions of this Agreement, Merck hereby grants to Metabasis, during the Research Term, a non exclusive, worldwide, royalty free license, without the right to sublicense, under the Merck Technology and Merck’s interest in the Joint Technology solely to perform Metabasis’ obligations under the Research Plan.
Collaboration License. Xxxxxxx, effective as of the Effective Date, hereby grants to DexCom a royalty-free, non-exclusive license, without the right to sublicense, under the Xxxxxxx Technology and any Software Copyrights assigned to Xxxxxxx pursuant to Section 6.1.4), solely for the purpose of, and limited to, DexCom’s performance of its activities under this Agreement and the Supply Agreement, to develop, make, have made, use, import, and export Licensed Product, for or on behalf of Xxxxxxx, in the Xxxxxxx Field, in the Territory.
Collaboration License. Biogen hereby grants to Catalyst, during the Research Term, a royalty-free, non-exclusive, worldwide license, with the right to sublicense (subject to the provisions of Section 2.2.4 (Sublicensing by Catalyst)), under the Biogen Technology solely for the purpose of performing the Catalyst Research Activities under the Work Plan.
